CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 31,603 enrolled
Drug / intervention
Atorvastatin Initiators +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01304641
NCT01304641N/ACompleted
CompareCT.gov

Comparison Of Cardiovascular Event Rates In Elderly Patients With Newly Initiated Atorvastatin Or Simvastatin

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.·observational·Posted Feb 25, 2011·Updated Feb 21, 2021

In Brief

An observational study evaluating Atorvastatin Initiators and Simvastatin Initiators for Cardiovascular and Dyslipidemia. Completed, enrolled 31,603 participants.

Detailed Summary

The purpose of this study is to compare rates and risk of primary cardiovascular events among elderly patients newly initiating therapy with atorvastatin or simvastatin. The specific objectives for this project are to: 1) examine the demographic and clinical characteristics of the elderly patients in whom atorvastatin or simvastatin was newly initiated; and 2) compare cardiovascular event rates in elderly patients in whom atorvastatin or simvastatin was newly initiated.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular, Dyslipidemia
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 25, 2011
Enrollment StartNov 1, 2009
Primary CompletionFeb 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 15.4 years ago

Interventions

Atorvastatin Initiatorsother

Retrospective database analysis no intervention performed.

Simvastatin Initiatorsother

Retrospective database analysis no intervention performed.